A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
Recruiting · NCT06830850 · Registry updated 2026-01-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer | Metastatic Castration Resistant Prostate Cancer | Recruiting | Phase 1 | 2026-01-15 | NCT06830850 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Atridia Pty Ltd. | 6 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Research SA | Adelaide | Australia | 3 |
| Eastern Health (Box Hill Hospital) | Melbourne | Australia | 1 |
| GenesisCare North Shore (Oncology) | Sydney | Australia | 1 |
| Icon Cancer Centre South Brisbane | Brisbane | Australia | 1 |
| Illawarra Shoalhaven Local Health District (Wollongong Hospital) | Wollongong | Australia | 1 |
| John Flynn Private Hospital | Brisbane | Australia | 1 |
| Linear Clinical Research Ltd | Perth | Australia | 1 |
| Macquarie University | Sydney | Australia | 4 |
| MUPharm Pty Limited trading as Macquarie University Hospital Pharmacy | Sydney | Australia | 1 |
| Southern Oncology Clinical Research Unit | Adelaide | Australia | 3 |
| Sydney Adventist Hospital | Sydney | Australia | 1 |